Tilray Inc Total Liabilities

Latest as of February 2026: CA$549.12 Million CAD ≈ $397.22 Million USD

Tilray Inc total liabilities. Based on the latest financial reports, Tilray Inc (TLRY) has total liabilities worth CA$549.12 Million CAD (≈ $397.22 Million USD) as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tilray Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Tilray Inc (2012–2025)

Total liabilities of Tilray Inc from 2012 to 2025. This chart illustrates how Tilray Inc's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Tilray Inc to see how much of total assets are deployed in long-term investments.

Tilray Inc Competitors by Total Liabilities

The table below lists competitors of Tilray Inc ranked by their total liabilities.

Company Country Total Liabilities
Ronshin Group A
SHE:301231
China CN¥134.42 Million
Rotshtein
TA:ROTS
Israel ILA1.57 Billion
Panin Financial Tbk
JK:PNLF
Indonesia Rp174.93 Trillion
Hainan Huluwa Pharmaceutical Group Co Ltd
SHG:605199
China CN¥2.13 Billion
FVCBankcorp Inc
NASDAQ:FVCB
USA $2.10 Billion
WCM Global Growth Ltd
AU:WQG
Australia AU$54.32 Million
CNlight Co Ltd
SHE:002076
China CN¥617.28 Million
Moury Construct SA
BR:MOUR
Belgium €100.34 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Tilray Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Tilray Inc's balance sheet.

Liquidity & Leverage Metrics

Tilray Inc Total Liabilities Ratios Explained

Tilray Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.79 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tilray Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tilray Inc (2012–2025)

The table below shows the annual total liabilities of Tilray Inc from 2012 to 2025.

Year Total Liabilities Change
2025-05-31 CA$584.75 Million
≈ $423.00 Million
-24.89%
2024-05-31 CA$778.49 Million
≈ $563.15 Million
-20.34%
2023-05-31 CA$977.32 Million
≈ $706.98 Million
-3.08%
2022-05-31 CA$1.01 Billion
≈ $729.41 Million
-35.37%
2021-05-31 CA$1.56 Billion
≈ $1.13 Billion
+227.82%
2020-05-31 CA$475.89 Million
≈ $344.25 Million
-9.11%
2019-05-31 CA$523.61 Million
≈ $378.77 Million
+380.55%
2018-05-31 CA$108.96 Million
≈ $78.82 Million
+248.65%
2017-05-31 CA$31.25 Million
≈ $22.61 Million
+3118.36%
2016-05-31 CA$971.04K
≈ $702.44K
+27.40%
2015-05-31 CA$762.17K
≈ $551.35K
+7204.72%
2014-05-31 CA$10.43K
≈ $7.55K
0.00%
2013-05-31 CA$10.43K
≈ $7.55K
-5.80%
2012-05-31 CA$11.08K
≈ $8.01K
--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic
Market Cap
$303.68 Million
CA$419.81 Million CAD
Market Cap Rank
#14448 Global
#425 in Canada
Share Price
CA$3.51
Change (1 day)
-4.62%
52-Week Range
CA$1.15 - CA$19.12
All Time High
CA$26.00
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more